These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10657866)

  • 21. Evaluation of ticarcillin/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma.
    Petrilli AS; Cypriano M; Dantas LS; Lee LM; Vercillo Luisi MF; Torres B Silva KV; Pires Pereira CA
    Braz J Infect Dis; 2003 Apr; 7(2):111-20. PubMed ID: 12959681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
    Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
    Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
    Mullen CA
    Pediatr Infect Dis J; 2003 Dec; 22(12):1138-42. PubMed ID: 14688588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized monocentric trial in febrile neutropenic patients: ceftriaxone and gentamicin vs cefepime and gentamicin.
    Cornely OA; Bethe U; Seifert H; Breuer K; Schütt-Gerowitt H; Salzberger B; Schrappe M; Fätkenheuer G
    Ann Hematol; 2002 Jan; 81(1):37-43. PubMed ID: 11807634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
    Kern WV; Cometta A; De Bock R; Langenaeken J; Paesmans M; Gaya H
    N Engl J Med; 1999 Jul; 341(5):312-8. PubMed ID: 10423465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia.
    Cooper MR; Durand CR; Beaulac MT; Steinberg M
    Ann Pharmacother; 2011 Sep; 45(9):1094-102. PubMed ID: 21862714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration].
    Karthaus M; Südhoff T; Fenchel K; Egerer G; Kämpfe D; Ritter J; Franke A; Heil G; Peters G; Jürgens H
    Wien Med Wochenschr; 1998; 148(21):481-7. PubMed ID: 10048176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Criteria of low risk of mortality in children with neutropenia and fever during cancer chemotherapy].
    Paganini HR; Rodríguez Brieshcke T; Zubizarreta P; Latella A; Firpo V; Fernandez C; Armada A; Casimir L; Debbag R
    Medicina (B Aires); 2001; 61(1):63-6. PubMed ID: 11265626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A
    Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
    Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftriaxone alone or in Combination with Teicoplanin in the Management of Febrile Episodes in Neutropenic Children and Adolescents with Cancer on an Outpatient Base.
    Preis S; Jürgens H; Friedland C; Oudekotte-David AA; Thomas L; Göbel U
    Klin Padiatr; 1993; 205(4):295-9. PubMed ID: 8377450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy.
    Laoprasopwattana K; Khwanna T; Suwankeeree P; Sujjanunt T; Tunyapanit W; Chelae S
    Pediatr Infect Dis J; 2013 Mar; 32(3):e94-8. PubMed ID: 23080291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer.
    Niho S; Ohe Y; Goto K; Ohmatsu H; Matsumoto T; Kubota K; Kakinuma R; Nishiwaki Y
    Jpn J Clin Oncol; 2004 Feb; 34(2):69-73. PubMed ID: 15067098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
    J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
    Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ceftriaxone and cefotaxime are equally effective in the treatment of neutropenic fever.
    Cornely OA; Salzberger B; Bethe U; Seifert H; Fätkenheuer G; Diehl V; Schrappe M
    Antibiot Chemother (1971); 2000; 50():37-46. PubMed ID: 10874453
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children.
    Leibovitz E; Janco J; Piglansky L; Press J; Yagupsky P; Reinhart H; Yaniv I; Dagan R
    Pediatr Infect Dis J; 2000 Nov; 19(11):1060-7. PubMed ID: 11099086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discontinuation of intravenous antibiotic therapy during persistent neutropenia in patients receiving prophylaxis with oral ciprofloxacin.
    Cornelissen JJ; Rozenberg-Arska M; Dekker AW
    Clin Infect Dis; 1995 Nov; 21(5):1300-2. PubMed ID: 8589161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.
    Gomez-Martin C; Solá C; Hornedo J; Perea S; Lumbreras C; Valentí V; Arcediano A; Rodriguez M; Salazar R; Cortés-Funes H; Hidalgo M
    J Clin Oncol; 2000 May; 18(10):2126-34. PubMed ID: 10811678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outpatient treatment of neutropenic fever with oral antibiotics and granulocyte colony-stimulating factor.
    Papadimitris C; Dimopoulos MA; Kostis E; Papadimitriou C; Anagnostopoulos A; Alexopoulos G; Papamichael C; Gika D; Mitsibounas D; Stamatelopoulos S
    Oncology; 1999; 57(2):127-30. PubMed ID: 10461059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.